+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • PDF Icon

    Report

  • 101 Pages
  • September 2023
  • Region: Global
  • GlobalData
  • ID: 5894340

Summary

This Medical Devices sector report, “Endocrinology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Endocrinology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Endocrinology Tests are the reagents used for quantification and detection of endocrine hormones secreted in the human body.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Endocrinology Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Endocrinology Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Endocrinology Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Endocrinology Tests Overview
3 Products under Development
3.1 Endocrinology Tests - Pipeline Products by Stage of Development
3.2 Endocrinology Tests - Pipeline Products by Segment
3.3 Endocrinology Tests - Pipeline Products by Territory
3.4 Endocrinology Tests - Pipeline Products by Regulatory Path
3.5 Endocrinology Tests - Pipeline Products by Estimated Approval Date
4 Endocrinology Tests - Pipeline Products under Development by Companies
4.1 Endocrinology Tests Companies - Pipeline Products by Stage of Development
4.2 Endocrinology Tests - Pipeline Products by Stage of Development
5 Endocrinology Tests Companies and Product Overview
6 Endocrinology Tests- Recent Developments
6.1 Aug 31, 2023: Integrated Diagnostics Holdings Announces Half Year Report
6.2 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
6.3 Jun 07, 2023: Eckert & Ziegler Strahlen Annual General Meeting Approves Dividend of EUR 0.50 per Share
6.4 Jun 01, 2023: Integrated Diagnostics announces Q1 2023 Results
6.5 Apr 06, 2023: Integrated Diagnostics Holdings Announces Final Results
6.6 Apr 06, 2023: Integrated Diagnostics Holdings concludes 2022 reporting solid 18% growth in non-Covid revenues
6.7 Feb 22, 2023: Novo Nordisk Notice for the Annual General Meeting
6.8 Dec 20, 2022: Eckert & Ziegler Announces Changes in the Supervisory Board
6.9 Dec 19, 2022: Eckert & Ziegler Announces Changes in the Management Board
6.10 Nov 17, 2022: Integrated Diagnostics Holdings 3rd Quarter Results
6.11 Oct 31, 2022: IDH and its Jordanian subsidiary, Biolab, to Launch Greenfield Diagnostic Venture in Saudi Arabia in Partnership with Izhoor Medical, a company owned by Fawaz Alhokair
6.12 Oct 05, 2022: DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument
7 Appendix
7.1 Methodology
7.2 About the Author
7.3 Contact Us
7.4 Disclaimer
List of Tables
Endocrinology Tests - Pipeline Products by Stage of Development
Endocrinology Tests - Pipeline Products by Segment
Endocrinology Tests - Pipeline Products by Territory
Endocrinology Tests - Pipeline Products by Regulatory Path
Endocrinology Tests - Pipeline Products by Estimated Approval Date
Endocrinology Tests Companies - Pipeline Products by Stage of Development
Endocrinology Tests - Pipeline Products by Stage of Development
Glossary
List of Figures
Endocrinology Tests - Pipeline Products by Stage of Development
Endocrinology Tests - Pipeline Products by Segment
Endocrinology Tests - Pipeline Products by Territory
Endocrinology Tests - Pipeline Products by Regulatory Path
Endocrinology Tests - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Albert Einstein College of Medicine
  • AMS Diagnostics LLC
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter Inc
  • Carolina Liquid Chemistries Corp
  • Celmatix Inc
  • Ceres Nanosciences Inc
  • Columbia University
  • Denka Seiken Co Ltd
  • DIANA Biotechnologies SRO
  • DiaSorin SpA
  • EDP Biotech Corporation
  • G Medical Health and Wellness
  • Guangzhou Wondfo Biotech Co Ltd
  • Hansjorg Wyss Institute for Biologically Inspired Engineering
  • I-Mab Biopharma Co Ltd
  • Intelligent Bio Solutions Inc
  • Laboratoire HRA Pharma SAS
  • MDNA Life Sciences Inc
  • MyHealthTest Pty Ltd
  • Revvity Inc
  • Roche Diagnostics International Ltd
  • Sendera Discovery
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Siemens Healthcare Diagnostics Inc
  • Solvd Health
  • Thermo Fisher Scientific Inc
  • Tosoh Bioscience Inc
  • University of California San Francisco